Sakar Healthcare Ltd.
SAKAR Share PricePharmaceuticals & Drugs
₹329.35
-3 (-0.9%)
As on September 8, 2025
Exchange Scrips: BSENSESAKARISININE732S01012
Market Cap ₹ 745 Cr
P/E Ratio 61.38
Dividend Yield N/A
Performance
Market performance
Open335
High335.5
Volumes20,196
Prev329.35
Low321.05
As on2025-09-08
Historical performance
1 Year High380.8
3 Year High479
5 Year High479
1 Year Low210.1
3 Year Low185.55
5 Year Low66.5
Fundamentals
Company Valuation
Market Cap (₹Cr)
745
Face Value (₹)
10
P/E Ratio
61.38
Dividend Yield
N/A
Investment Returns
1 Year
1.9%
3 Years
46.4%
5 Years
372.9%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 335.87 | Bearish |
| 10-DMA | 333.75 | Bearish |
| 20-DMA | 330.12 | Bearish |
| 50-DMA | 342.11 | Bearish |
| 100-DMA | 327.25 | Bullish |
| 200-DMA | 300.87 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 4 | 4 | 4 | 4 | 4 |
| Public Investors | 8111 | 8604 | 8594 | 7863 | 7309 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 61.38.
- 3Y Stock Price CAGR of the stock is 15.1.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹416 Million.
- The company generated revenue of ₹1534 Million in the previous financial year.
Sakar Healthcare Ltd.
329.35-3 (-0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1021715.5
No. of Shares: 3102 (Approx)
Performance:2.2%
P/L: ₹21715.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent